Title : Inhibition of cyclin A kinase activity in E2F-1 chemogene therapy of colon cancer.

Pub. Date : 2002 Nov-Dec

PMID : 12677090






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ad-E2F-1 treatment alone results in 3.4-fold increase of cyclin A kinase activity compared to Ad-LacZ control (p < 0.05); when combined with chemotherapeutic agents, cyclin A kinase activity was inhibited significantly by VIN, actinomycin D, and etoposide (p < 0.005), but not with CPT, CIS, and 5-FU (p > 0.1) compared to Ad-E2F-1 treatment alone. Etoposide cyclin A2 Homo sapiens
2 Ad-E2F-1 treatment alone results in 3.4-fold increase of cyclin A kinase activity compared to Ad-LacZ control (p < 0.05); when combined with chemotherapeutic agents, cyclin A kinase activity was inhibited significantly by VIN, actinomycin D, and etoposide (p < 0.005), but not with CPT, CIS, and 5-FU (p > 0.1) compared to Ad-E2F-1 treatment alone. Etoposide cyclin A2 Homo sapiens